DIAMPA LT 25/5MG TAB

DIAMPA LT 25/5MG is a combination tablet containing Empagliflozin 25mg and Linagliptin 5mg. This dual-action formulation is designed to help manage type 2 diabetes by improving blood sugar control through two complementary mechanisms. Empagliflozin works by increasing glucose excretion through urine, while Linagliptin enhances insulin secretion in response to elevated blood sugar levels. Suitable for patients requiring combination therapy to achieve optimal glycemic control. Always use as directed by your healthcare provider.